Xiaodong Feng is Dean and Professor at the College of Pharmacy, California Northstate University. He earned his PhD in Cellular and Molecular Physiology from the Chinese Academy of Medical Sciences and his PharmD from Albany College of Pharmacy and Health Sciences. He is an oncology pharmacy specialist and holds multiple U.S. and international patents on anti-angiogenesis therapies and cancer drug targets, and leads multi-institutional projects in pharmacogenomics and oncology drug development. He has edited three textbooks on pharmacogenomics, biologic and biosimilar drug development, and advanced pharmacology for prescribers. His teaching disciplines span oncology, pharmacogenomics, and pharmacy education, while his research interests focus on anti-angiogenesis, cancer immunotherapy, biosimilars, and pharmacovigilance.
